CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR

Figure 6

A nomogram and calibration curves for prediction of one-, two-, and three-year overall survival rates of patients with PAAD. (a, e) A nomogram for prediction of one-, two-, and three-overall survival rates of patients with PAAD with high expression of CTSK and PLAU. (b–d, f–h) Calibration curves of the nomogram prediction of one-, two-, and three-year overall survival rates of patients with PAAD with high expression of CTSK and PLAU.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)